Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;5(11):100902.
doi: 10.1016/S2666-5247(24)00134-4. Epub 2024 Aug 13.

WHO global research priorities for antimicrobial resistance in human health

Collaborators, Affiliations
Review

WHO global research priorities for antimicrobial resistance in human health

Silvia Bertagnolio et al. Lancet Microbe. 2024 Nov.

Abstract

The WHO research agenda for antimicrobial resistance (AMR) in human health has identified 40 research priorities to be addressed by the year 2030. These priorities focus on bacterial and fungal pathogens of crucial importance in addressing AMR, including drug-resistant pathogens causing tuberculosis. These research priorities encompass the entire people-centred journey, covering prevention, diagnosis, and treatment of antimicrobial-resistant infections, in addition to addressing the overarching knowledge gaps in AMR epidemiology, burden and drivers, policies and regulations, and awareness and education. The research priorities were identified through a multistage process, starting with a comprehensive scoping review of knowledge gaps, with expert inputs gathered through a survey and open call. The priority setting involved a rigorous modified Child Health and Nutrition Research Initiative approach, ensuring global representation and applicability of the findings. The ultimate goal of this research agenda is to encourage research and investment in the generation of evidence to better understand AMR dynamics and facilitate policy translation for reducing the burden and consequences of AMR.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests SBe, ZD, CMC, HHB, NG, MH-A, BA, HS, TW, BDH, and VI are WHO employees. KVW and ACa were WHO employees. KUK and SBu are WHO consultants. ACh, DD, RLH, and IDO were WHO consultants. RLH is also supported by the Wellcome Trust (106680/Z/14/Z). All authors declare no other competing interests. Declarations of competing interests of the collaborators for the WHO research agenda for AMR in human health were reviewed and are available upon request to the corresponding author.

Figures

Figure 1
Figure 1
Identification of the 40 research priorities in the WHO agenda for research on antimicrobial resistance and human health LMICs=low-income and middle-income countries.
Figure 2
Figure 2
Details of experts involved (A) Geographical distribution of experts. (B) Number of experts by research discipline (data missing for 15 experts). (C) Number of experts in each antimicrobial resistance area (experts could report more than one research discipline and area of expertise).

References

    1. Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–655. - PMC - PubMed
    1. The Lancet Antimicrobial resistance: an agenda for all. Lancet. 2024;403:2349. - PubMed
    1. WHO . World Health Organization; Geneva: Jan 1, 2016. Global action plan on antimicrobial resistance.https://iris.who.int/handle/10665/253236
    1. WHO . World Health Organization; Geneva: Sept 4, 2017. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis.https://www.who.int/publications/i/item/WHO-EMP-IAU-2017.12
    1. WHO . World Health Organization; Geneva: Oct 25, 2022. WHO fungal priority pathogens list to guide research, development and public health action.https://apps.who.int/iris/handle/10665/363682

MeSH terms

Substances